Evidence map›Paper›PMID 39351463›Full record

ArticleWorld journal of clinical oncology2024

Study on the expression and prognostic relationship of

Hai-Bing Lv, Qing-Yun Wu, Yu-Jiao Zhang, Sheng-Wei Quan, Ning Ma, Yu-Qing Dai, Yan Sun

Abstract read
In one paragraph

Article in World journal of clinical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hai-Bing LvDepartment of General Surgery, Beidahuang Group General Hospital, Harbin 150000, Heilongjiang Province, China.
Qing-Yun WuDepartment of General Surgery, Xianning Central Hospital, Xianning 437000, Hubei Province, China.
Yu-Jiao ZhangDepartment of Medical oncology, Beidahuang Group General Hospital, Harbin 150000, Heilongjiang Province, China.
Sheng-Wei QuanDepartment of General Surgery, Beidahuang Group General Hospital, Harbin 150000, Heilongjiang Province, China.
Ning MaDepartment of General Surgery, Daqing Oilfield General Hospital, Daqing 163000, Heilongjiang Province, China.
Yu-Qing DaiCollege of Clinical Medicine, Bengbu Medical University, Bengbu 233000, Anhui Province, China.
Yan SunDepartment of General Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150000, Heilongjiang Province, China. sunyan202405@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary liver cancer is a prevalent and deadly cancer type. Despite treatment advances, prognosis remains poor, with high recurrence rates. Early detection is crucial but challenging due to the disease's insidious nature. Myosin proteins play significant roles in cancer development, influencing cell migration, invasion, and tumor suppression.

aimTo investigate the expression of

methodsThe expression of

results

conclusionThe expression level of

Indexed as

BioinformaticsExpressionLiver cancerMYL6BPrognosis

Identifiers

PMID39351463
PMCPMC11438851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.